Study identifier:D3461R00072
ClinicalTrials.gov identifier:NCT06314282
EudraCT identifier:N/A
CTIS identifier:N/A
INTERSTELLAR - Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
Systemic lupus erythematosus (SLE)
N/A
No
-
All
200
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Feb 2025 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|